<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T05:43:41Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/6919" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/6919</identifier><datestamp>2025-10-24T10:56:14Z</datestamp><setSpec>com_2072_451667</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_451668</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women</dc:title>
   <dc:creator>Cruz-Lemini, Mónica</dc:creator>
   <dc:creator>Ferriols Pérez, Elena</dc:creator>
   <dc:creator>de la Cruz, María Luisa</dc:creator>
   <dc:creator>Caño Aguilar, Africa</dc:creator>
   <dc:creator>Encinas Pardilla, Maria Begoña</dc:creator>
   <dc:creator>Prats, P</dc:creator>
   <dc:creator>Rodríguez, Agueda</dc:creator>
   <dc:subject>COVID-19 (Malaltia)</dc:subject>
   <dc:subject>Embaràs</dc:subject>
   <dc:subject>DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections</dc:subject>
   <dc:subject>PHENOMENA AND PROCESSES::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproduction::Pregnancy</dc:subject>
   <dc:subject>DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Asymptomatic Diseases::Asymptomatic Infections</dc:subject>
   <dc:subject>ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus</dc:subject>
   <dc:subject>FENÓMENOS Y PROCESOS::fenómenos fisiológicos reproductivos y urinarios::fenómenos fisiológicos de la reproducción::reproducción::embarazo</dc:subject>
   <dc:subject>ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::enfermedades asintomáticas::infecciones asintomáticas</dc:subject>
   <dcterms:abstract>Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Embaràs; Infecció asimptomàtica</dcterms:abstract>
   <dcterms:abstract>Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Embarazo; Infección asintomática</dcterms:abstract>
   <dcterms:abstract>Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Pregnancy; Asymptomatic infection</dcterms:abstract>
   <dcterms:abstract>Around two percent of asymptomatic women in labor test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Spain. Families and care providers face childbirth with uncertainty. We determined if SARS-CoV-2 infection at delivery among asymptomatic mothers had different obstetric outcomes compared to negative patients. This was a multicenter prospective study based on universal antenatal screening for SARS-CoV-2 infection. A total of 42 hospitals tested women admitted for delivery using polymerase chain reaction, from March to May 2020. We included positive mothers and a sample of negative mothers asymptomatic throughout the antenatal period, with 6-week postpartum follow-up. Association between SARS-CoV-2 and obstetric outcomes was evaluated by multivariate logistic regression analyses. In total, 174 asymptomatic SARS-CoV-2 positive pregnancies were compared with 430 asymptomatic negative pregnancies. No differences were observed between both groups in key maternal and neonatal outcomes at delivery and follow-up, with the exception of prelabor rupture of membranes at term (adjusted odds ratio 1.88, 95% confidence interval 1.13-3.11; p = 0.015). Asymptomatic SARS-CoV-2 positive mothers have higher odds of prelabor rupture of membranes at term, without an increase in perinatal complications, compared to negative mothers. Pregnant women testing positive for SARS-CoV-2 at admission for delivery should be reassured by their healthcare workers in the absence of symptoms.</dcterms:abstract>
   <dcterms:abstract>This project was supported by public funds obtained in competitive calls: Grant COV20/00021 (EUR 43,000 from the Instituto de Salud Carlos III—Spanish Ministry of Health and co-financed with Fondo Europeo de Desarrollo Regional (FEDER) funds. Dr Cruz-Lemini is supported by a Juan Rodés contract JR19/00047, Instituto de Salud Carlos III—Spanish Ministry of Health. The funding bodies had no role in the study design, in the collection or analysis of the data, or in manuscript writing.</dcterms:abstract>
   <dcterms:dateAccepted>2025-10-24T10:56:14Z</dcterms:dateAccepted>
   <dcterms:available>2025-10-24T10:56:14Z</dcterms:available>
   <dcterms:created>2025-10-24T10:56:14Z</dcterms:created>
   <dcterms:issued>2022-01-27T13:07:24Z</dcterms:issued>
   <dcterms:issued>2022-01-27T13:07:24Z</dcterms:issued>
   <dcterms:issued>2021-01-15</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:identifier>http://hdl.handle.net/11351/6919</dc:identifier>
   <dc:relation>Viruses;13(1)</dc:relation>
   <dc:relation>https://doi.org/10.3390/v13010112</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>MDPI</dc:publisher>
   <dc:source>Scientia</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>